针对晚期泌尿腺癌的向治疗方法的景观
Shihao Shang1, Lei Zhang1, Kepu Liu1
1Department of Urology, Xijing Hospital, Fourth Military Medical University, Xi'an 710032, Shaanxi, China.
Exploration of targeted anti-tumor therapy
|July 5, 2024
概括
晚期膀癌 (aUC) 治疗需要除了化疗和免疫疗法之外的新选择. 本综述探讨了针对性疗法和分子改变,以获得更好的aUC结果.
科学领域:
- 在瘤学瘤学.
- 遗传学 是一个遗传学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 膀癌 (BC) 是一个全球性的健康问题,尿道癌 (UC) 是主要的亚型.
- 先进的UC (aUC) 呈现出不良的预后和有限的生存率与当前的治疗方法,如化疗和免疫治疗.
- 由于现有治疗方法的适度疗效,因此急需新的治疗策略.
研究的目的:
- 审查与晚期泌尿腺癌 (aUC) 相关的当前分子变化.
- 讨论目前用于aUC的临床研究中的向治疗干预措施.
- 探索针对aUC的新型向药物和组合疗法的潜力.
主要方法:
- 在晚期泌尿腺癌中分子变化的文献综述.
- 分析当前的向治疗选择和临床试验.
- 讨论新兴的向药物和组合治疗策略.
主要成果:
- 先进的UC表现出高瘤突变负担和众多分子变化.
- 埃尔达菲提尼布是FDA批准的唯一针对aUC的向疗法.
- 目前正在针对aUC的各种分子标进行研究,许多向疗法正在研究中.
结论:
- 在aUC中的分子变化为开发向治疗提供了基础.
- 目前正在进行的研究正在探索新的向药物和组合方法.
- 向疗法有望改善晚期UC的临床结果.
相关概念视频
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
01:27Tumor Immunotherapy
509
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
509
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K